Literature DB >> 12086971

IL-12p40 is associated with type 1 diabetes in Caucasian-American families.

Abdoreza Davoodi-Semiromi1, James J Yang, Jin-Xiong She.   

Abstract

The IL-12p40 locus has recently been shown to be associated with type 1 diabetes (1). Here, we report the identification of novel microsatellite and single-nucleotide polymorphisms (SNPs) within the IL-12p40 gene and a significant association between a (ATT)n repeat marker and type 1 diabetes in 364 U.S. Caucasian sib-pair families (P < 0.006). Haplotype analysis using the (ATT)n repeat (D5S2941) and the C1159A SNP at the 3' untranslated region of IL-12p40 showed a significant association (P = 0.02). Expression studies in individuals heterozygous for the C1159A SNP indicated that the expression of the 1159A allele is approximately 50% higher than that of the 1159C allele. These results provide genetic and functional evidence for IL-12p40 as a type 1 diabetes susceptibility gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086971     DOI: 10.2337/diabetes.51.7.2334

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

Review 2.  Genetic epidemiology of type 1 diabetes.

Authors:  Andrew D Paterson
Journal:  Curr Diab Rep       Date:  2006-04       Impact factor: 4.810

3.  Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.

Authors:  Andrzej Roszak; Adrianna Mostowska; Anna Sowińska; Margarita Lianeri; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2012-05-22       Impact factor: 3.201

4.  Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.

Authors:  G Morahan; E McKinnon; J Berry; B Browning; C Julier; F Pociot; I James
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

5.  Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm.

Authors:  Li-Juan Li; Xin-Min Pan; Xiutian Sima; Zhao-Hui Li; Lu-Shun Zhang; Hong Sun; Yi Zhu; Wei-Bo Liang; Lin-Bo Gao; Lin Zhang
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

6.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

7.  Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection.

Authors:  Li-Min Yin; Wan-Fu Zhu; Lai Wei; Xiao-Yuan Xu; De-Gui Sun; Yan-Bin Wang; Wen-Mei Fan; Min Yu; Xiu-Lan Tian; Qi-Xin Wang; Yan Gao; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

8.  Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients.

Authors:  A E Altinova; D Engin; E Akbay; M Akturk; F Toruner; R Ersoy; I Yetkin; M Arslan
Journal:  J Endocrinol Invest       Date:  2009-12-22       Impact factor: 4.256

9.  Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.

Authors:  Alicja E Grzegorzewska; Piotr M Wobszal; Adrianna Mostowska; Paweł P Jagodziński
Journal:  BMC Nephrol       Date:  2012-08-03       Impact factor: 2.388

10.  Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment.

Authors:  Eliana Peresi; Larissa Ragozo Cardoso Oliveira; Weber Laurentino da Silva; Erika Alessandra Pellison Nunes da Costa; João Pessoa Araujo; Jairo Aparecido Ayres; Maria Rita Parise Fortes; Edward A Graviss; Ana Carla Pereira; Sueli Aparecida Calvi
Journal:  Tuberc Res Treat       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.